Cargando…

Alcoholic liver disease: A registry view on comorbidities and disease prediction

Alcoholic-related liver disease (ALD) is the cause of more than half of all liver-related deaths. Sustained excess drinking causes fatty liver and alcohol-related steatohepatitis, which may progress to alcoholic liver fibrosis (ALF) and eventually to alcohol-related liver cirrhosis (ALC). Unfortunat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grissa, Dhouha, Nytoft Rasmussen, Ditlev, Krag, Aleksander, Brunak, Søren, Juhl Jensen, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531835/ https://www.ncbi.nlm.nih.gov/pubmed/32960884 http://dx.doi.org/10.1371/journal.pcbi.1008244

Ejemplares similares

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021)

Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022)

Noninvasive proteomic biomarkers for alcohol-related liver disease
por: Niu, Lili, et al.
Publicado: (2022)

Diseases 2.0: a weekly updated database of disease–gene associations from text mining and data integration
por: Grissa, Dhouha, et al.
Publicado: (2022)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients
por: Jensen, Anders Boeck, et al.
Publicado: (2014)

A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
por: Åberg, Fredrik, et al.
Publicado: (2021)

Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population
por: Eriksson, Robert, et al.
Publicado: (2014)

Erratum to: Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population
por: Eriksson, Robert, et al.
Publicado: (2014)

Cyclebase.org: version 2.0, an updated comprehensive, multi-species repository of cell cycle experiments and derived analysis results
por: Gauthier, Nicholas Paul, et al.
Publicado: (2010)

Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text
por: Eriksson, Robert, et al.
Publicado: (2013)

Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines
por: Warrer, Pernille, et al.
Publicado: (2015)

Circular reasoning rather than cyclic expression
por: Jensen, Lars Juhl, et al.
Publicado: (2008)

A comprehensive and quantitative comparison of text-mining in 15 million full-text articles versus their corresponding abstracts
por: Westergaard, David, et al.
Publicado: (2018)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records
por: Hjaltelin, Jessica Xin, et al.
Publicado: (2023)

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts: Medium-Term Assessment of Outcomes and Complications
por: Ng, Pui Yung, et al.
Publicado: (2013)

Time-ordered comorbidity correlations identify patients at risk of mis- and overdiagnosis
por: Jørgensen, Isabella Friis, et al.
Publicado: (2021)

Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA
por: Eriksson, Robert, et al.
Publicado: (2014)

Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types
por: Hjaltelin, Jessica Xin, et al.
Publicado: (2019)

Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? — A Cross‐Sectional Study Using Liver Biopsy and Dual‐Energy X‐Ray Absorptiometry
por: Hansen, Stinus Gadegaard, et al.
Publicado: (2023)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Cyclebase.org—a comprehensive multi-organism online database of cell-cycle experiments
por: Gauthier, Nicholas Paul, et al.
Publicado: (2008)

Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease
por: Banasik, Karina, et al.
Publicado: (2011)

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data
por: Grissa, Dhouha, et al.
Publicado: (2016)

Comorbidity landscape of the Danish patient population affected by chromosome abnormalities
por: Jørgensen, Isabella Friis, et al.
Publicado: (2019)

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease
por: Madsen, Bjørn S., et al.
Publicado: (2021)

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease
por: Trebicka, Jonel, et al.
Publicado: (2022)

Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
por: Kotlyarov, Stanislav
Publicado: (2023)

Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data mining
por: Kirk, Isa Kristina, et al.
Publicado: (2019)

Preferences predict who commits crime among young men
por: Epper, Thomas, et al.
Publicado: (2022)

Protein-driven inference of miRNA–disease associations
por: Mørk, Søren, et al.
Publicado: (2014)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
por: Jichitu, Alexandra, et al.
Publicado: (2021)

The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease
por: Nowak, Aleksander J., et al.
Publicado: (2020)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e82uvq6caq5mf5p4ths9vftpu